Cancer System Quality Index by Cancer Care Ontario
This year, for the first time, the publication of the annual Cancer System Quality Index by Cancer Care O...
Read moreResearch & Access Updates
New Canadian pharmaceutical company brings novel cancer therapies to market
(Toronto, Ont.) January 27, 2021 ¬– FORUS Therapeutics launches today, bringing a new pharmaceutical comp...
Read moreLifetime Pesticide Use and Monoclonal Gammopathy of Undetermined Significance in a Prospective Cohort of Male Farmers
Farmers have a higher incidence of multiple myeloma, and there is suggestive evidence of an elevated prev...
Read moreReal‐world outcomes with bortezomib‐containing regimens and lenalidomide plus dexamethasone for the treatment of transplant‐ineligible multiple myeloma
Extract o the report: Bortezomib‐containing regimens (BCRs) represented standard, first‐line therapy f...
Read moreMyeloma Canada invests a yearly record-high $735,000 in Canadian myeloma research projects
Myeloma Canada invested in more important research initiatives in 2020 than in any other year, thanks to...
Read moreInaugural Coverage of the 62nd ASH Annual Meeting & Exposition by the CMRG.
Take a look at this all-virtual 4-day event recap, with a 90-minute panel discussion on the CMRG YouTube...
Read more